Clofarabine solution
Based on 17 publication(s) in Google Scholar
Clofarabine solution is mainly composed of Clofarabine (HY-A0005). Clofarabine, a nucleoside analogue for research of cancer, is a potent inhibitor of ribonucleotide reductase (IC50=65 nM) by binding to the allosteric site on the regulatory subunit.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 123318-82-1
- Formule: C10H11ClFN5O3
- Masse moléculaire:303.68
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
CAS No. 123318-82-1
-
Masse moléculaire 303.68
-
Formule C10H11ClFN5O3
-
SMILES
O[C@H]1[C@H](F)[C@H](N(C=N2)C3=C2C(N)=NC(Cl)=N3)O[C@@H]1CO
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (17)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responses. [Abstract]2025 Dec 15;10(1):406. PMID: 41392286 -
Nat Metab
Uridine-sensitized screening identifies demethoxy-coenzyme Q and NUDT5 as regulators of nucleotide synthesis. [Abstract]2025 Nov 13. PMID: 41233602 -
-
Cell Death Dis
2026 Feb 26;17(1):275. PMID: 41748545 -
J Immunother Cancer
Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway. [Abstract]2025 Feb 6;13(2):e010252. PMID: 39915005
Clofarabine solution purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2025 Feb 6;13(2):e010252. [Abstract]
The cell viability of A375, A549, and PIG1 treated with Clofarabine (Clo) (1.25, 2.5, 5, 10, 20 μM) for 24 hours and 48 hours was measured by CCK8 assay.
Clofarabine solution purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2025 Feb 6;13(2):e010252. [Abstract]
Flow cytometry was conducted to determine the apoptosis of A375 and A549 treated with Clofarabine (Clo) (30 nM, 60 nM, 1 μM, 1.5 μM) for 48 hours.
Clofarabine solution purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2025 Feb 6;13(2):e010252. [Abstract]
The number of colonies of A375 and A549 treated with Clofarabine (Clo) for 48 hours was measured after crystal violet staining.
Clofarabine solution purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2025 Feb 6;13(2):e010252. [Abstract]
Schematic diagram of Clofarabine (Clo) (30 mg/kg, i.g.) for melanoma treatment. Tumor growth and body weight curves for B16F10 tumor-bearing mice receiving the designated treatments.
Clofarabine solution purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2025 Feb 6;13(2):e010252. [Abstract]
Western blotting revealed the protein expression of P53, p-P53, cGAS, STING, p-IkBα, BAX, Cleaved Caspase-3, Cleaved Caspase-6, and Cleaved PARP in lysates collected from A375 and A549 treated with Clofarabine (Clo).
-
Acta Pharmacol Sin
Esflurbiprofen exerts a fast-onset antidepressant effect by blocking SERT-nNOS interaction. [Abstract]2025 Oct 9. PMID: 41068287 -
Cell Rep
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D. [Abstract]2025 Nov 23;44(12):116596. PMID: 41284383 -
Biochem Pharmacol
Dual inhibition of EGR1/STAT3 transcriptional hubs suppresses macrophage-driven liver fibrosis: A multi-omics-guided drug repurposing strategy. [Abstract]2025 Oct:240:117120. PMID: 40623460 -
Pharmaceuticals (Basel)
Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis. [Abstract]2024 Sep 28;17(10):1295. PMID: 39458936 -
Int J Antimicrob Agents
2019 Dec;54(6):814-819. PMID: 31479744 -
J Mol Med (Berl)
2019 Aug;97(8):1183-1193. PMID: 31201471 -
J Cell Mol Med
2026 Apr;30(7):e71101. PMID: 41896195 -
Front Oncol
Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia. [Abstract]2024 Jul 19:14:1440650. PMID: 39099696 -
Biochem Biophys Res Commun
Connectivity-map unveils Gemcitabine's efficacy in overcoming nelarabine resistance in T-cell acute lymphoblastic leukemia. [Abstract]2025 Jul 8:769:151971. PMID: 40354678 -
-
bioRxiv
Uridine-sensitized screening identifies genes and metabolic regulators of nucleotide synthesis. [Abstract]2025 Mar 13:2025.03.11.642569. PMID: 40161720 -
Oncotarget
2020 Nov 3;11(44):3921-3932. PMID: 33216841
Pureté et documentation
Références
[1]. Peter L Bonate, et al. Discovery and development of clofarabine: a nucleoside analogue for treating cancer. Nat Rev Drug Discov. 2006 Oct;5(10):855-63. [Content Brief]
[2]. Hai-Bo Liu, et al. [Effect of clofarabine on proliferation and Bcl-2 expression of NB4 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):571-3. [Content Brief]
[3]. Jia-Jie Luan, et al. Dosing-time contributes to chronotoxicity of clofarabine in mice via means other than pharmacokinetics. Kaohsiung J Med Sci. 2016 May;32(5):227-34. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)